Post–COVID-19 syndrome has affected millions of people, with rehabilitation being at the center of non-pharmacologic care. However, numerous published studies show conflicting results due to, among other factors, considerable variation in subject characteristics. Currently, the effects of age, sex, time of implementation, and prior disease severity on the outcomes of a supervised rehabilitation program after COVID-19 remain unknown.
METHODS:
This was a non-randomized case-control study. Subjects with post–COVID-19 sequelae were enrolled. Among study participants, those who could attend an 8-week, supervised rehabilitation program composed the intervention group, whereas those who couldn’t the control group. Measurements were collected at baseline and 8 weeks thereafter.
RESULTS:
Study groups (N = 119) had similar baseline measurements. Participation in rehabilitation (n = 47) was associated with clinically important improvements in the 6-min walk test (6MWT) distance, adjusted (for potential confounders) odds ratio (AOR) 4.56 (95% CI 1.95–10.66); 1-min sit-to-stand test, AOR 4.64 (1.88-11.48); Short Physical Performance Battery, AOR 7.93 (2.82–22.26); health-related quality of life (HRQOL) 5-level EuroQol-5D (Visual Analog Scale), AOR 3.12 (1.37–7.08); Montreal Cognitive Assessment, AOR 6.25 (2.16–18.04); International Physical Activity Questionnaire, AOR 3.63 (1.53–8.59); Fatigue Severity Scale, AOR 4.07 (1.51–10.98); Chalder Fatigue Scale (bimodal score), AOR 3.33 (1.45–7.67); Modified Medical Research Council dyspnea scale (mMRC), AOR 4.43 (1.83–10.74); Post–COVID-19 Functional Scale (PCFS), AOR 3.46 (1.51–7.95); and COPD Assessment Test, AOR 7.40 (2.92–18.75). Time from disease onset was marginally associated only with 6MWT distance, AOR 0.99 (0.99–1.00). Prior hospitalization was associated with clinically important improvements in the mMRC dyspnea scale, AOR 3.50 (1.06–11.51); and PCFS, AOR 3.42 (1.16–10.06). Age, sex, and ICU admission were not associated with the results of any of the aforementioned tests/grading scales.
CONCLUSIONS:
In this non-randomized, case-control study, post–COVID-19 rehabilitation was associated with improvements in physical function, activity, HRQOL, respiratory symptoms, fatigue, and cognitive impairment. These associations were observed independently of timing of rehabilitation, age, sex, prior hospitalization, and ICU admission.
DavisHE, McCorkellL, VogelJM, TopolEJ. Long COVID: major findings, mechanisms, and recommendations. Nat Rev Microbiol, 2023; 21(3):133-146.
2.
SinghSJ, BaldwinMM, DaynesE, EvansRA, GreeningNJ, JenkinsRG, et al. Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins and approaches to clinical care and rehabilitation. Lancet Respir Med, 2023; 11(8):709-725.
3.
Meléndez-OlivaE, Martínez-PozasO, Cuenca-ZaldívarJN, VillafañeJH, Jiménez-OrtegaL, Sánchez-RomeroEA. Efficacy of pulmonary rehabilitation in post–COVID-19: a systematic review and meta-analysis. Biomedicines, 2023; 11(8):2213.
4.
ReinertG, MüllerD, WagnerP, Martínez-PozasO, Cuenca-ZáldivarJN, Fernández-CarneroJ, et al. Pulmonary rehabilitation in SARS-CoV-2: a systematic review and meta-analysis of post-acute patients. Diagn Basel Switz, 2022; 12(12):3032.
5.
SonnweberT, SahanicS, PizziniA, LugerA, SchwablC, SonnweberB, et al. Cardiopulmonary recovery after COVID-19: an observational prospective multi-center trial. Eur Respir J, 2021; 57(4):2003481.
6.
CarvalhoAC, MoreiraJ, CubeloP, CantistaP, Aguiar BrancoC, GuimarãesB. Multidisciplinary rehabilitation in intensive care for COVID-19: randomized controlled trial. ERJ Open Res, 2023; 9(1):00350-02022.
7.
GloecklR, LeitlD, JaroschI, SchneebergerT, NellC, StenzelN, et al. Benefits of pulmonary rehabilitation in COVID-19: a prospective observational cohort study. ERJ Open Res, 2021; 7(2):00108-02021.
8.
AsimakosA, SpetsiotiS, MavronasouA, GounopoulosP, SiousiouraD, DimaE, et al. Additive benefit of rehabilitation on physical status, symptoms, and mental health after hospitalisation for severe COVID-19 pneumonia. BMJ Open Respir Res, 2023; 10(1):e001377.
9.
EvansRA, McAuleyH, HarrisonEM, ShikotraA, SingapuriA, SerenoM, et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multi-center, prospective cohort study. Lancet Respir Med, 2021; 9(11):1275-1287.
10.
PHOSP-COVID Collaborative Group. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med, 2022; 10(8):761-775.
11.
McCarthyA, GalvinR, DockeryF, McLoughlinK, O’ConnorM, CoreyG, et al. Multidisciplinary inpatient rehabilitation for older adults with COVID-19: a systematic review and meta-analysis of clinical and process outcomes. BMC Geriatr, 2023; 23(1):391.
12.
SpruitMA, HollandAE, SinghSJ, ToniaT, WilsonKC, TroostersT. COVID-19: interim guidance on rehabilitation in the hospital and post-hospital phase from a European Respiratory Society-and American Thoracic Society–coordinated international task force. Eur Respir J, 2020; 56(6).
13.
SinghSJ, BarradellAC, GreeningNJ, BoltonC, JenkinsG, PrestonL, et al. British Thoracic Society survey of rehabilitation to support recovery of the post–COVID-19 population. BMJ Open, 2020; 10(12):e040213.
AntoniouKM, VasarmidiE, RussellA-M, AndrejakC, CrestaniB, DelcroixM, et al. European Respiratory Society statement on long COVID-19 follow-up. Eur Respir J, 2022; 60(2).
16.
SinghSJ, PuhanMA, AndrianopoulosV, HernandesNA, MitchellKE, HillCJ, et al. An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. Eur Respir J, 2014; 44(6):1447-1478.
17.
LiJ, XiaW, ZhanC, LiuS, YinZ, WangJ, et al. A telerehabilitation program in post-discharge COVID-19 patients (TERECO): a randomized controlled trial. Thorax, 2022; 77(7):697-706.
18.
CrookS, BüschingG, SchultzK, LehbertN, JelusicD, KeuschS, et al. A multi-center validation of the 1-min sit-to-stand test in patients with COPD. Eur Respir J, 2017; 49(3).
19.
PapathanasiouG, GeorgoudisG, PapandreouM, SpyropoulosP, GeorgakopoulosD, KalfakakouV, et al. Reliability measures of the short International Physical Activity Questionnaire (IPAQ) in Greek young adults. Hellenic J Cardiol, 2009; 50(4):283-294.
20.
JonesPW, HardingG, BerryP, WiklundI, ChenW-H, LeidyNK. Development and first validation of the COPD Assessment Test. Eur Respir J, 2009; 34(3):648-654.
21.
DaynesE, GerlisC, ChaplinE, GardinerN, SinghSJ. Early experiences of rehabilitation for individuals post-COVID to improve fatigue, breathlessness exercise capacity, and cognition - A cohort study. Chron Respir Dis, 2021; 18:14799731211015691.
22.
Global Initiative for Chronic Obstructive Lung Disease. 2023 GOLD Report, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Available at: https://goldcopd.org/2023-gold-report-2. Accessed October 19, 2023.
23.
KruppLB, LaRoccaNG, Muir-NashJ, SteinbergAD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol, 1989; 46(10):1121-1123.
24.
JacksonC. The Chalder fatigue scale (CFQ 11). Occup Med (Lond), 2015; 65(1):86.
25.
KlokFA, BoonGJAM, BarcoS, EndresM, GeelhoedJJM, KnaussS, et al. The Post–COVID-19 Functional Status (PCFS) Scale: a tool to measure functional status over time after COVID-19. Eur Respir J, 2020; 56(1).
26.
NasreddineZS, PhillipsNA, BédirianV, CharbonneauS, WhiteheadV, CollinI, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc, 2005; 53(4):695-699.
27.
NolanCM, LongworthL, LordJ, CanavanJL, JonesSE, KonSSC, et al. The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness, and minimum important difference. Thorax, 2016; 71(6):493-500.
28.
WareJE, SherbourneCD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care, 1992; 30(6):473-483.
29.
BorgGA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc, 1982; 14(5):377-381.
30.
SawyerA, CavalheriV, HillK. Effects of high-intensity interval training on exercise capacity in people with chronic pulmonary conditions: a narrative review. BMC Sports Sci Med Rehabil, 2020; 12(1):22.
31.
SpruitMA, SinghSJ, GarveyC, ZuWallackR, NiciL, RochesterCet al; ATS/ERS Task Force on Pulmonary Rehabilitation. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med, 2013; 188(8):e13-64-e64.
WuQ, HouX, LiH, GuoJ, LiY, YangF, et al. A follow-up study of respiratory and physical function after discharge in patients with redetectable positive SARS-CoV-2 nucleic acid results following recovery from COVID-19. Int J Infect Dis, 2021; 107:5-11.
37.
SantusP, TursiF, CroceG, Di SimoneC, FrassanitoF, GaboardiP, et al. Changes in quality of life and dyspnoea after hospitalization in COVID-19 patients discharged at home. Multidiscip Respir Med, 2020; 15(1):713.
38.
van HaastregtJCM, EverinkIHJ, ScholsJMGA, GrundS, GordonAL, PootEP, et al. Management of post-acute COVID-19 patients in geriatric rehabilitation: EuGMS guidance. Eur Geriatr Med, 2022; 13(1):291-304.
39.
LiuK, ZhangW, YangY, ZhangJ, LiY, ChenY. Respiratory rehabilitation in elderly patients with COVID-19: a randomized controlled study. Complement Ther Clin Pract, 2020; 39:101166.
40.
RochesterCL, VogiatzisI, HollandAE, LareauSC, MarciniukDD, PuhanMAet al; ATS/ERS Task Force on Policy in Pulmonary Rehabilitation. An Official American Thoracic Society/European Respiratory Society policy statement: enhancing implementation, use, and delivery of pulmonary rehabilitation. Am J Respir Crit Care Med, 2015; 192(11):1373-1386.
41.
PourhoseingholiMA, BaghestaniAR, VahediM. How to control confounding effects by statistical analysis. Gastroenterol Hepatol Bed Bench, 2012; 5(2):79-83.
42.
FergusonB. ACSM’s guidelines for exercise testing and prescription 9th ed. 2014. J Can Chiropr Assoc, 2014; 58(3):328.
43.
American Association of Cardiovascular and Pulmonary Rehabilitation. Guidelines for pulmonary rehabilitation programs, 5th edition. Champaign, Illinois: Human Kinetics, Inc; 2020.
44.
BoltonCE, Bevan-SmithEF, BlakeyJD, CroweP, ElkinSL, GarrodRet al; British Thoracic Society Standards of Care Committee. British Thoracic Society guideline on pulmonary rehabilitation in adults: accredited by NICE. Thorax, 2013; 68 Suppl 2(Suppl 2):ii1-i30.
45.
GarveyC, BaylesMP, HammLF, HillK, HollandA, LimbergTM, et al. Pulmonary rehabilitation exercise prescription in chronic obstructive pulmonary disease: review of selected guidelines: an official statement from the American Association of Cardiovascular and Pulmonary Rehabilitation. J Cardiopulm Rehabil Prev, 2016; 36(2):75-83.
46.
DaynesE, BaldwinM, GreeningNJ, YatesT, BishopNC, MillsG, et al. The effect of COVID rehabilitation for ongoing symptoms Post HOSPitalisation with COVID-19 (PHOSP-R): protocol for a randomized parallel group controlled trial on behalf of the PHOSP consortium. Trials, 2023; 24(1):61.
47.
HollandAE, CoxNS, Houchen-WolloffL, RochesterCL, GarveyC, ZuWallackR, et al. Defining modern pulmonary rehabilitation. An official American Thoracic Society Workshop report. Ann Am Thorac Soc, 2021; 18(5):e12-e29.
